SLE is an autoimmune condition causing symptoms such as joint swelling AstraZeneca has received approval from the US Food and ...
Presentation Date / Time : Friday, May 1, 2026 / 2:55 p.m. to 6:00 p.m. EDT ...
Obexelimab Phase 3 win, SLE catalyst, pipeline updates (ZB014, orelabrutinib), and cash runway—read now. Click for a ZBIO ...
InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the ...
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for obinutuzumab for the treatment of systemic lupus erythematosus (SLE). Findings ...
The FDA has approved a self-administered autoinjector form of anifrolumab for the treatment of systemic lupus erythematosus, ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...
The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus erythematosus.
In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
A new review article highlights a number of roles for B1 cells, including antibody secretion and the stimulation of CD4+ cells. B cells are known to play a role in systemic lupus erythematosus (SLE), ...
Objectives To assess indirect costs (IDC) due to lost productivity in paid/unpaid labour, stratified by sex, in a national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results